Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 13/20 | 1.00 |
| ▸ | CNR2 | P34972 | 12/20 | 0.94 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | HTR3A | P46098 | 1/20 | 0.46 |
| ▸ | CFD | P00746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29361630 | 1.00 | CNR1 (1.00) | CNR1CNR2KDM4EHTR3ACFD | |
| SCHEMBL31052997 | 1.00 | CNR1 (1.00) | CNR1CNR2KDM4EHTR3ACFD | |
| SCHEMBL25367439 | 0.92 | CNR1 (0.85) | CNR1CNR2KDM4EHTR3A | |
| SCHEMBL25367435 | 0.92 | CNR1 (0.85) | CNR1CNR2KDM4EHTR3A | |
| SCHEMBL17613431 | 0.91 | CNR1 (0.83) | CNR1CNR2KDM4EHTR3ACFD | |
| SCHEMBL29019203 | 0.91 | CNR1 (0.98) | CNR1CNR2KDM4EHTR3A | |
| SCHEMBL21140768 | 0.90 | CNR1 (1.00) | CNR1CNR2KDM4EHTR3A | |
| SCHEMBL17613430 | 0.90 | CNR1 (0.81) | CNR1CNR2KDM4EHTR3ACFD | |
| SCHEMBL29822416 | 0.90 | CNR1 (1.00) | CNR1CNR2KDM4EHTR3A | |
| SCHEMBL30032574 | 0.90 | CNR1 (0.81) | CNR1CNR2KDM4EHTR3ACFD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160084859-A1 | DETECTION OF INDAZOLE SYNTHETIC CANNABINOIDS | RANDOX LABORATORIES LIMITED (GB) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160084859-A1 | DETECTION OF INDAZOLE SYNTHETIC CANNABINOIDS | CNR2, CNR1, HRH4 | CNR1 2/4885CNR2 1/4885KDM4E 2620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.